Concepedia

Leena Rahmat

LR

Statistics

Publications

4

Citations

147

H-Index

4

Active since

2018

Affiliations

Johns Hopkins University(Current)

University of California, San Francisco

Leena Rahmat is an author at Johns Hopkins University specializing in oncology, medicine, and hematopoietic stem cell transplant pharmacotherapy.

ORCID

Publications per year

2018–2021

4

Publications

4

Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Theodore C. Tarver, Jason E. Hill, Leena Rahmat et al. · Blood Advances · 2020 · 76 citations · Full text

, , +14

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant

Leena Rahmat, Anna Nguyen, Haifaa Abdulhaq et al. · Case Reports in Hematology · 2018 · 43 citations · Full text

, , +16

Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide

Katherine Rappazzo, Marianna Zahurak, Maria Bettinotti et al. · Transplantation and Cellular Therapy · 2021 · 16 citations · Full text

, , +14

The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia

Leena Rahmat, Lloyd E. Damon · Case Reports in Hematology · 2018 · 12 citations · Full text

, , +17

1–4 of 4